No image

AccuSign® MTD card

DOA-208-10-02 · Princeton Biomeditech Corporation

AccuSign® MTD card; 10 Test kit; CE

Details

Device typeMethadone IVD, kit, rapid ICT, clinical: A collection of reagents and other associated materials intended to be used for the qualitative and/or (semi-)quantitative detection of methadone in a clinical specimen within a short period, relative to standard laboratory testing procedures, using an immunochromatographic test (ICT) method [lateral flow test]. This is a rapid test used in the laboratory or in point-of-care analyses. It is not intended to be used for self-testing.

FDA categoryEnzyme Immunoassay, Methadone

Device ID10743816000198

Catalog numberDOA-208-10-02

Single useYes

MRI safetyLabeling does not contain MRI Safety Information

Contact

Phone732-274-1000

Emailinfo@pbmc.com

Related products

Product	Model	Company	Device type
First Sign®Hemosure Inc.Multiple drugs of abuse IVD, kit, rapid ICT, clinical	FSCDIPMT-25	Hemosure Inc.	Multiple drugs of abuse IVD, kit, rapid ICT, clinical
QuickProfile™ Methamphetamine Test CardLumiquick Diagnostics, Inc.Multiple drugs of abuse IVD, kit, rapid ICT, clinical	07RD7006	Lumiquick Diagnostics, Inc.	Multiple drugs of abuse IVD, kit, rapid ICT, clinical
AIMSCREEN METGermaine Laboratories, IncMethamphetamine-specific IVD, kit, rapid ICT, clinical	47125	Germaine Laboratories, Inc	Methamphetamine-specific IVD, kit, rapid ICT, clinical
QMedix™Diagnostic Automation, Inc.Benzodiazepine group IVD, kit, rapid ICT, clinical	DACD121061-1-19	Diagnostic Automation, Inc.	Benzodiazepine group IVD, kit, rapid ICT, clinical